Markets.com Logo
markets.com

PDS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

PDS Biotech, Inc. (PDS.US) is a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer and infectious diseases. Their proprietary Versamune® T-cell activating technology platform is designed to overcome immune suppression and generate a potent, targeted T-cell attack against disease cells. PDS Biotech's lead product candidate, PDS0101, is being evaluated in multiple clinical trials for various HPV-associated cancers, often in combination with other therapies. The company is also developing other Versamune-based immunotherapies for different cancers and infectious diseases.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

**Financial Performance**: Revenue, earnings, and profitability trends significantly impact investor sentiment. Strong financial results generally drive the stock price upward. **Industry Trends**: The overall health and growth prospects of the pharmaceutical distribution industry affect investor confidence in PDS.US. Positive trends typically benefit the stock. **Regulatory Environment**: Changes in healthcare regulations, drug pricing policies, and distribution laws can influence PDS.US's profitability and market position. **Economic Conditions**: Economic growth, interest rates, and inflation can affect consumer spending on healthcare products and thus, PDS.US's performance. **Competitive Landscape**: Actions of competitors, mergers, and acquisitions within the pharmaceutical distribution industry can impact PDS.US's market share and pricing power. **Company-Specific News**: New product launches, partnerships, leadership changes, and strategic initiatives specific to PDS.US influence investor expectations. **Market Sentiment**: General market conditions, investor risk appetite, and overall stock market trends can influence the demand for PDS.US shares. **Dividend Policy**: Dividend payments and changes in dividend policy can attract or deter investors, affecting the stock price. **Analyst Ratings**: Recommendations and price targets from financial analysts can influence investor perceptions of PDS.US's value. **Global Events**: Major global events, such as pandemics or geopolitical tensions, can disrupt supply chains and affect demand for pharmaceutical products, influencing PDS.US's stock.

People Also Watch

Latest news

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Julian Parker|--
McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

Julian Parker|--
Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Julian Parker|--

Latest Education Articles

Risk Management 101

Risk Management 101

Julian Parker|--
Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Julian Parker|--
Gold Scalping Strategy: How Scalping XAU/USD Works

Gold Scalping Strategy: How Scalping XAU/USD Works

Julian Parker|--
Recommended Topics
markets.com